About Index Trending news
Analyze
Top 50 Pricing
ASLAN Pharma

ASLAN Pharma

Work at ASLAN Pharma? Add yourself to this profile

ASLAN Pharma

ASLAN Pharmaceuticals is an oncology-focused biotechnology company developing a portfolio of immuno-oncology agents and targeted therapies.

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding
Venture capital (Series D)
$23,000,000
Milestone Capital China, Daiwa Taiwan, Taya Ventures, +3
Venture capital (Series C)
$43,000,000
Morningside Group, MVP Capital Partners, Accuron Technologies Limited, +5
Employees

Unknown size

Locations
HQ
Headquarters
$23,000,000 Venture capital (Series D)
Biotechin.Asia

Biotech company Aslan Pharmaceuticals Raises US$23 Million In Pre-IPO FinancingĀ Round

$43,000,000 Venture capital (Series C)
FinSMEs

Aslan Pharmaceuticals Raises Additional $9M; Closes $43M in Series C Funding

Health Funding